InsidersTradesSigma
Follow the 바이오인프라 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오인프라 has recorded 12 insider filings. The latest transaction was reported on 8 June 2026 (Purchase). Among the most active insiders: 김장현. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
BioInfra is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance human health.